# Artiva Biotherapeutics, Inc.: Form 8-K, filed Jul 22, 2026

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: 8-K
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 17:15 ET
- Period: 2026-07-22
- Accession: 0001193125-26-312560
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/artv-20260722.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/artv-20260722.htm

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-312560. Last ingested by Listed: Nov 10, 2026, 01:58 ET. No prices; not investment advice.
